Preliminary Scientific Schedule for NPC Symposium 2015
Day1:
4-Jun-15
Etiology of NPC
08.00 - 09.00
09.00 - 09.30
Registration
Opening
Professor I. Bing Tan, MD, PhD (Netherlands Cancer
Institute/AVL Hospital Amsterdam, NL-Universitas Gadjah
Mada Yogyakarta Indonesia)
09.30 - 10.00
Keynote Address
10.00 - 10.30
Coffee Break
10.30 - 12.00
PLENARY 1 : Epidemiology (World distribution, Molecular epidemiology, and Risk factors)
10.30 - 10.50
World NPC Incidence and Risk Factors
Ellen Chang, Sc.D (Stanford Cancer Institute, LA, CA,USA)
10.50 - 11.10
Familial NPC and the Use of Biomarkers
Professor Chien-Jen Chen (Genomics Research Center,
Academia Sinica; and Graduate Institute of Epidemiology
and Preventive Medicine, National Taiwan University,
Taipei, Taiwan)
11.10 - 11.20
Hospital-Based Incidence of NPC in Indonesia
Marlinda Adham, MD, PhD (Universitas Indonesia, Rumah
Sakit Cipto Mangunkusumo, Jakarta, Indonesia)
11.20 - 12.00
12.00 - 13.00
13.00 - 14.50
Free Papers (4)
Lunch
PLENARY 2: Genetic/Epigenetic
Genetic Susceptibility Risk Factors for Sporadic and
Familial NPC: Recent Findings
Exome Sequencing and GWAS Studies on Sporadic
NPC
Results of GWAS and Exome Sequencing of Familia
NPC
13.00 - 13.20
13.20 - 13.40
13.40 - 14.00
14.00 - 14.20
Epigenetics on NPC
14.20 - 14.50
14.50 - 15.05
15.05 - 18.00
Free Papers (3)
Coffee Break
PLENARY 3: EBV-Host Relationship
15.05 - 15.25
Role of Exosome in NPC
15.25 - 15.45
EBV (EBNA1)
15.45 - 16.05
Studies on EBV and Host Relationship
16.05 - 16.35
16.35 - 18.00
Free Papers (3)
Poster Reception (High Tea Reception)
Allan Hildesheim, PhD (DCEG, NCI, USA)
Professor Jinxin Bei (Sun Yat-sen University Cancer Center,
Guangzhou, China)
James McKay, PhD (IARC, Lyon, France)
Prof. Qian Tao (School of Biomedical Sciences, The
Chinese University of Hong Kong, China)
Pierre Busson, PhD (Institut de Cancérologie Gustave
Roussy, Villejuif, Cedex, France)
Lori Frappier, PhD (Dept of Molecular Genetics, University
of Toronto, Canada)
Professor Kwok-Wai Lo (University of Hong Kong, Hong
Kong)
Day 2:
5-Jun-15
Screening, Diagnosis and Treatment of NPC
Time
Program
08.00 - 10.00
PLENARY 4: NPC Screening and Awareness
08.00 - 08.20
NPC Screening Implementation in China
08.20 - 08.40
EBV Array Platform to Screen for EBV Antibodies
Associated with NPC and Other EBV-Associated
Disorders
08.40 - 09.00
NPC awareness
09.00 - 09.30
09.30 - 10.00
10.00 - 13.35
Free paper (3 Paper)
Coffee Break
PLENARY 5: Clinical Diagnosis NPC
10.00 - 10.20
Advance Imaging on NPC
10.20 - 10.40
The Advanced Role of Ultrasound in Detecting Early
Oropharyngeal Cancer Lesion
10.40 - 11.30
11.30 - 13.15
13.15 13.15 - 13.35
13.35 - 14.05
14.05 - 14.25
14.25 - 15.45
14.25 - 14.45
14.45-15.05
Panel Discussion: Challenges of NPC Diagnosis in
Developing Countries
Speaker
Su-Mei Cao, MD, PhD (Sun Yat-sen University Cancer
Center, China)
Professor Denise Doolan (QIMR Berghofer Medical
Research Institute, The University of Queensland,
Australia)
Sagung Rai Indrasari, MD, MSc
(Universitas Gadjah Mada/Dr. Sardjito Hospital
Yogyakarta,Indonesia)
Professor Ann D. King, MB BCh, MRCP, FRCR, FHKCR,
FHKAM (The Chinese University of Hong Kong,
China)
Carole Fahkry, MD (Greater Baltimore Medical
Center and The John Hopkins Hospital, USA)
a. Alan Khoo Soo Beng, MD (Institute for Medical
Research, Ministry of Health, Malaysia)
b. Marlinda Adham, MD, PhD (Universitas
Indonesia/Rumah Sakit Cipto Mangunkusumo,
Jakarta,Indonesia)
c. Sagung Rai Indrasari, MD, MSc (Universitas Gadjah
Mada/Dr. Sardjito Hospital Yogyakarta,Indonesia)
Lunch and Friday Praying
PLENARY 6: Therapy: State of the Art on Primary Treatment of NPC
Current Advances and Future Direction in NPC
Professor Brian O'Sullivan, MB Bch BAO, FRCPC
Management
(University of Toronto, Toronto, Canada)
Prof. Dr. med. Rolf Mertens (Universitätsklinikum
Management for Juvenile NPC
Aachen Klinik f. Kinder- und Jugendmedizin,
Germany)
Free Papers (3)
PLENARY 7: Treatment Failure in NPC
Chen Ming Yuan, PhD ( Affiliated Hospital of Zunyi
Management of Treatment Failure in NPC
Medical College, Guangzhou, China)
Prof. Anne Lee (Department of Clinical Oncology,
Global Pattern and Correlation of Outcome with
Pamela Youde Nethersole Eastern Hospital,
Access to Radiotherapy for NPC
Hongkong)
15.05- 16.00
East-West Discussion on NPC Management
16.00 - 16.15
16.15 - 18.00
18.00 - 21.00
Afternoon Coffee
Break
Cultural Night
a. Johan Kurnianda, MD
(Universitas Gadjah Mada/Dr. Sardjito Hospital
Yogyakarta,Indonesia)
b. Prof. Dr. dr. Soehartati G., Sp.Rad(K), Onk.Rad
(Universitas Indonesia/Rumah Sakit Cipto
Mangunkusumo, Jakarta,Indonesia)
c. Prof. I. Bing Tan MD, PhD.
(Netherlands Cancer Institute-Universitas Gadjah
Mada Yogyakarta, Indonesia)
d. Professor Brian O’Sullivan, MB Bch BAO, FRCPC
(University of Toronto, Toronto, Canada)
Day 3:
6-Jun-15
Novel Approaches for NPC Diagnosis and Treatment
Time
Program
08.30 - 10.00 PLENARY 8: Novel Biomarker
08.30 - 08.50
EBV-based diagnosis and prognostic
indicator
08.50 - 09.10 Prognostic/predictive marker
Speaker
Professor Maria Li Lung (Li Ka Shing Faculty of
Medicine, The University of Hong Kong, Hong Kong)
Professor Mu-Sheng Zeng, MD, PhD (Cancer Institute,
Sun Yat-sen University, China)
09.10 - 10.00 Free papers (5)
10.00 - 10.30 Coffee break
10.30 - 10.35
Announcement of NPC Gordon
Research Conference 2016
Professor Maria Li Lung (Li Ka Shing Faculty of
Medicine, The University of Hong Kong, Hong Kong)
10.35 - 15.05 PLENARY 9: Immunology and Immunotheraphy
10.35 - 10.55 Role of HLA and KIR in NPC
10.55 - 11.15
The Role of Potentially Neutralizing
Antibodies Against EBV in NPC
11.55 - 12.35
12.35 - 13.30
13.30 - 15.00
15.00 - 15.30
Anna E. Coghill, MD (National Cancer Institute,
Rockville, USA)
Professor Rajiv Khanna (QIMR Berghofer Medical
Research Institute, University of Queensland,
Australia)
Results on Immunotheraphy in Clinical Toh Han Chong, MD (National Cancer Centre,
Trials
Singapore)
Free Papers (4)
Lunch Break
Satellites for Free Papers (2-4 satellites)
Nutrition
Palliative Care
Awareness
Herbals
Others
Closing and Announcement for Next Meeting
11.15 - 11.35 Polytope Vaccine for NPC
11.35 - 11.55
Xiaojiang Gao, PhD (Leidos Biomedical Research, Inc.,
Frederick National Laboratory for Cancer Research
National Cancer Institute, The Netherlands)